An Update on Herbal Products for the Management of Inflammatory Bowel Disease

Antiinflamm Antiallergy Agents Med Chem. 2023;22(1):1-9. doi: 10.2174/1871523022666230727094250.

Abstract

Inflammatory Bowel Disease (IBD), including Ulcerative Colitis (UC) and Crohn's Disease (CD), is a continuously increasing healthcare problem mainly characterized by chronic relapsing intestinal inflammation. The common symptoms of UC and CD include inflammation, diarrhea, abdominal pain, bleeding, and weight loss. IBD is generally caused by an interaction between genetic and environmental or microbial factors that influence the body's immune response and is responsible for digestive disorders and inflammation of the intestinal tract. However, a complete understanding of the pathophysiology and work-up of IBD is necessary to ensure appropriate treatment for the management of this complex disease. This review enlightens herbal therapeutics and drug delivery systems for the management of IBD, and thus provides new insights into this field and facilitates access to new treatments.

Keywords: Crohn’s Disease (CD); IBD treatment; Inflammatory Bowel Disease (IBD); Ulcerative Colitis (UC); digestive disorder; medicinal plants.

Publication types

  • Review

MeSH terms

  • Colitis, Ulcerative* / complications
  • Colitis, Ulcerative* / drug therapy
  • Colitis, Ulcerative* / genetics
  • Crohn Disease* / diagnosis
  • Crohn Disease* / drug therapy
  • Crohn Disease* / etiology
  • Humans
  • Inflammation
  • Inflammatory Bowel Diseases* / drug therapy